Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy ; volume:12 ; number:1 ; day:13 ; month:1 ; year:2021 ; pages:1-7 ; date:12.2021
Nature Communications ; 12, Heft 1 (13.1.2021), 1-7, 12.2021
- Creator
-
Gromeier, Matthias
Brown, Michael C.
Zhang, Gao
Lin, Xiang
Chen, Yeqing
Wei, Zhi
Beaubier, Nike
Yan, Hai
He, Yiping
Desjardins, Annick
Herndon, James E.
Varn, Frederick S.
Verhaak, Roel G.
Zhao, Junfei
Bolognesi, Dani P.
Friedman, Allan H.
Friedman, Henry S.
McSherry, Frances
Muscat, Andrea M.
Lipp, Eric S.
Nair, Smita K.
Khasraw, Mustafa
Peters, Katherine B.
Randazzo, Dina
Sampson, John H.
McLendon, Roger E.
Bigner, Darell D.
Ashley, David M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-020-20469-6
- URN
-
urn:nbn:de:101:1-2021020800220325152618
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gromeier, Matthias
- Brown, Michael C.
- Zhang, Gao
- Lin, Xiang
- Chen, Yeqing
- Wei, Zhi
- Beaubier, Nike
- Yan, Hai
- He, Yiping
- Desjardins, Annick
- Herndon, James E.
- Varn, Frederick S.
- Verhaak, Roel G.
- Zhao, Junfei
- Bolognesi, Dani P.
- Friedman, Allan H.
- Friedman, Henry S.
- McSherry, Frances
- Muscat, Andrea M.
- Lipp, Eric S.
- Nair, Smita K.
- Khasraw, Mustafa
- Peters, Katherine B.
- Randazzo, Dina
- Sampson, John H.
- McLendon, Roger E.
- Bigner, Darell D.
- Ashley, David M.
- SpringerLink (Online service)
Other Objects (12)
A REST derived gene signature stratifies glioblastomas into chemotherapy resistant and responsive disease
Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy
Microenvironment‐Responsive Prodrug‐Induced Pyroptosis Boosts Cancer Immunotherapy
Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
Somatic retrotransposition is infrequent in glioblastomas
Stimuli‐Responsive Nanocarriers as Active Enhancers of Antitumoral Immunotherapy
Heterogeneous activation of the TGFβ pathway in glioblastomas identified by gene expression-based classification using TGFβ-responsive genes
Optimizing T cell inflamed signature through a combination biomarker approach for predicting immunotherapy response in NSCLC
GATA4 and DcR1 methylation in glioblastomas
Bevacizumab for patients with recurrent multifocal glioblastomas
Tumor microenvironment-responsive metal nanotherapeutics for breast cancer chemo-/immunotherapy
Dual‐Responsive Supramolecular Polymeric Nanomedicine for Self‐Cascade Amplified Cancer Immunotherapy
A REST derived gene signature stratifies glioblastomas into chemotherapy resistant and responsive disease
Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy
Microenvironment‐Responsive Prodrug‐Induced Pyroptosis Boosts Cancer Immunotherapy
Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
Somatic retrotransposition is infrequent in glioblastomas
Stimuli‐Responsive Nanocarriers as Active Enhancers of Antitumoral Immunotherapy
Heterogeneous activation of the TGFβ pathway in glioblastomas identified by gene expression-based classification using TGFβ-responsive genes
Optimizing T cell inflamed signature through a combination biomarker approach for predicting immunotherapy response in NSCLC
GATA4 and DcR1 methylation in glioblastomas
Bevacizumab for patients with recurrent multifocal glioblastomas
Tumor microenvironment-responsive metal nanotherapeutics for breast cancer chemo-/immunotherapy
Dual‐Responsive Supramolecular Polymeric Nanomedicine for Self‐Cascade Amplified Cancer Immunotherapy
A REST derived gene signature stratifies glioblastomas into chemotherapy resistant and responsive disease
Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy
Microenvironment‐Responsive Prodrug‐Induced Pyroptosis Boosts Cancer Immunotherapy
Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
Somatic retrotransposition is infrequent in glioblastomas
Stimuli‐Responsive Nanocarriers as Active Enhancers of Antitumoral Immunotherapy
Heterogeneous activation of the TGFβ pathway in glioblastomas identified by gene expression-based classification using TGFβ-responsive genes
Optimizing T cell inflamed signature through a combination biomarker approach for predicting immunotherapy response in NSCLC
GATA4 and DcR1 methylation in glioblastomas
Bevacizumab for patients with recurrent multifocal glioblastomas
Tumor microenvironment-responsive metal nanotherapeutics for breast cancer chemo-/immunotherapy